Ginkgo Bioworks Holdings (DNA) Interest Expenses (2020 - 2024)
Ginkgo Bioworks Holdings (DNA) reported Interest Expenses of $31.4 million for Q4 2024, down 28.72% on a YoY basis from $44.0 million in Q1 2024, and up 439.09% quarter-over-quarter from -$9.3 million in Q3 2024.
Ginkgo Bioworks Holdings (DNA) Interest Expenses (2020 - 2024) Analysis & Trends
Ginkgo Bioworks Holdings has reported Interest Expenses for 4 years, with the latest figure at $31.4 million in Q4 2024.
- For the quarter ending Q4 2024, Interest Expenses fell 28.72% year-over-year to $31.4 million; the trailing twelve-month figure through Sep 2025 stood at $31.4 million (up 28.34% YoY), and the FY2024 full-year result was $94000.0, up 1.08% from the prior year.
- Interest Expenses for Q4 2024 stood at $31.4 million, up from -$9.3 million in the prior quarter.
- The five-year high for Interest Expenses was $44.0 million in Q4 2023, with the low at -$15.0 million in Q3 2023.
- Historically, Interest Expenses has averaged $2.9 million across 4 years, with a median of $570500.0 in 2020.
- The largest YoY upside for Interest Expenses was 38.41% in 2024 against a maximum downside of 28.72% in 2024.
- Ginkgo Bioworks Holdings' Interest Expenses stood at $590000.0 in 2020, then declined by 6.61% to $551000.0 in 2021, then surged by 7886.75% to $44.0 million in 2023, then decreased by 28.72% to $31.4 million in 2024.
- The last three Interest Expenses figures came in at $31.4 million (Q4 2024), -$9.3 million (Q3 2024), and -$10.3 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -5.58 Mn |
| 10 | Ginkgo Bioworks Holdings | 466.98 Mn | 466.98 Mn | 16.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 31.37 Mn |
| Dec 31, 2024 | 31.37 Mn |
| Sep 30, 2024 | -9.25 Mn |
| Sep 30, 2024 | -9.25 Mn |
| Jun 30, 2024 | -10.31 Mn |
| Jun 30, 2024 | -10.31 Mn |
| Dec 31, 2023 | 44.01 Mn |
| Dec 31, 2023 | 44.01 Mn |
| Sep 30, 2023 | -15.02 Mn |
| Sep 30, 2023 | -15.02 Mn |
| Jun 30, 2023 | -14.35 Mn |
| Jun 30, 2023 | -14.35 Mn |
| Dec 31, 2021 | 551,000.00 |
| Dec 31, 2021 | 551,000.00 |
| Sep 30, 2021 | 649,000.00 |
| Sep 30, 2021 | 649,000.00 |
| Dec 31, 2020 | 590,000.00 |
| Dec 31, 2020 | 590,000.00 |
| Sep 30, 2020 | 592,000.00 |
| Sep 30, 2020 | 592,000.00 |